TECHWIRE 30
(CIX: WRAL30)  1,178.35    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: Apple)  98.66    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NY: Q)  74.03    (0 %)  Updated: 08:04 PM EDT, Jul 22 2016
(OP: BASFY)  78.54    (0 %)  Updated: 05:20 PM EDT, Jul 22 2016
(NQ: BCRX)  3.08    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: BDSI)  2.39    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: CEMP)  18.08    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: Cisco)  30.71    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: CREE)  28.48    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EST, Dec 04 2015
(NY: EMC)  28.41    (0 %)  Updated: 08:04 PM EDT, Jul 22 2016
(NQ: EXTR)  3.88    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NQ: Facebook)  121.00    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NY: GSK)  43.88    (0 %)  Updated: 08:04 PM EDT, Jul 22 2016
(NQ: Alphabet)  742.74    (0 %)  Updated: 08:10 PM EDT, Jul 22 2016
(NY: IBM)  162.07    (0 %)  Updated: 08:04 PM EDT, Jul 22 2016

Posts tagged “GSK”

June 29

IBM, GSK at Biden cancer summit; Mars booster fires (video); Zuck's wall; hepatitis C pill

In today's Bulldog wrapup of life science and technology news: IBM's Watson to tackle cancer and GSK to speed up drug development; NASA fires a Mars booster (see video, photos); Mark Zuckerberg's new wall angers neighbors in Hawaii; and the FDA approves a pill to treat hepatitis C.

June 23

Premium Lock Tech Links: IBM Watson medical imaging; Google, AT&T vs. FCC; Lenovo smartphone supply chain; Tencent gaming buy; good GSK drug news

High tech In today's Tech Links roundup of news impacting the Triangle: IBM forms a new Watson alliance for assessment of medical imaging - 2 reports; the FCC may budge on its cable box proposal after hearing opposition from AT&T and Google; Lenovo vows to revamp its supply chain to right smartphone business; Tencent, which owns a big part of Cary-based Epic Games, buys "Clash of Clans" creator; and GSK gets good news on a COPD combination therapy.

June 14

Premium Lock Longtime GSK exec, vaccine leader Moncef Slaoui to retire

Dr. Moncef Slaoui Dr. Moncef Slaoui, a longtime GlaxoSmithKline executive who currently heads vaccine development and who led research and development for the drug giant earlier in his career, is retiring.

Updated June 9

Premium Lock Tech links: Cisco shuffle; Chuck Robbins video; GSK arthritis drug; IBM exec on women in IT

High tech In today's wrapup of headlines on news impacting the Triangle tech community: Cisco's exec shuffle continues to generate headlines; Cisco CEO Chuck Robbins' video interview at Recode; GSK gets good news on an arthritis drug; and IBM's top IoT exec and Harriet Green on women in IT.

June 7

Premium Lock Tech links: 5G 'blistering' speed; GSK Avandia case; IBM $300M deal; Lenovo data center updates

High tech In today's "Tech links" wrapup of other media reports about news affecting the Triangle: AT&T reports blistering speeds at 5G lab; GSK loses bid to toss Avandia racketeering lawsuits; IBM wins a $300 million contract; and Lenovo adds new data center products as well as new partners.

May 25

Premium Lock Tech links: IBM's cognitive dress; Cisco cloud phone; Watson on Twilio; GSK lung drug success; Lenovo Moto Z

In today's roundup of Tech Links, taking you to important stories affecting tech in the Triangle: Check out the "cognitive dress" designed in part by IBM's Watson; see a YouTube video about the fashion project; read about Cisco's cloud phone; find out about new Watson services for developers at Twilio, GSK gets good news on a potential lung drug; and Lenovo trademarks Moto Z.

May 20

Premium Lock Tech links: 'Watson' at Moogest; free Cisco IoT training; AT&T connects cars; Red Hat bitcoin; Epic grants; China drug prices

High tech In today's tech Links roundup of news affecting Triangle companies: IBM's Watson at Moogfest; Cisco plans free IoT training online; AT&T links cars and data; Red Hat offers more details on its bitoin initiative; Epic Games awards $75,000 in grants; and China slashes prices for GSK, AstraZeneca drugs.

May 4

Premium Lock Triangle headlines: GSK sells RTP buildings; Nortel bankruptcy ruling; Lenovo's $500M investment fund; Chinese firms like NC

Triangle headlines In today's wrapup of Triangle area news: GSK sells its RTP buildings but plans to lease them back; a ruling may lead to Nortel bankruptcy settlement; Lenovo plans to invest $500 million in startups; and Chinese firms show a liking for North Carolina.

Updated April 27

Premium Lock 'Ecouraging start:' GSK sees rise in sales of vaccines, healthcare products

Pharmaceutical company GlaxoSmithKline says higher sales of vaccines and consumer healthcare products pushed up its earnings from core business by 19 percent in the first quarter. CEO Andrew Witty sees the results as an "encouraging start" for the year.

March 31

Premium Lock GSK moving to make more drugs available in poor countries

GSK   GSK said today it is taking steps to bring its medicines to more people living in the world's poorest countries.

Updated March 17

Premium Lock GSK CEO: Retirement not related to calls for giant's breakup

Andrew Witty  Drug giant GlaxoSmithKline made news official what had been rumored for months: CEO Andrew Witty is going to retire. Witty plans to step down a year from now. However, he says his decision is not linked to investor calls for breakup of the company.

March 17

Premium Lock GSK's CEO makes it official: He's retiring next year

Drug giant GlaxoSmithKline made news official what had been rumored for months: CEO Andrew Witty is going to retire. Witty plans to step down a year from now.

GSK's Andrew Witty on the ground in Africa GSK's Andrew Witty on the ground in Africa

Updated February 29

Premium Lock Reports: GSK begins search for successor to CEO Andrew Witty

Drug giant GlaxoSmithKline is preparing to launch what is called a "formal search" for a successor to Chief Executive Officer Andrew Witty, reports the prestigious Financial Times as well as the Reuters news service.

GSK's Andrew Witty on the ground in Africa GSK's Andrew Witty on the ground in Africa

February 22

Premium Lock GSK wraps up $1.46B HIV drug pipeline deal with Bristol-Myers Squibb

GSK's HQ in London             GlaxoSmithKline is boosting its own efforts to fight AIDS by closing on a deal to buy the HIV drug pipeline of Bristol-Myers Squibb . The transaction is worth as much as $1.46 billion. In May, GSK said it would invest $20 million in a deal with UNC-Chapel Hill to develop an AIDS cure.

Updated February 12

Premium Lock British government fines GSK $54M for delaying generic drugs

GSK in Zebulon  Britain's competition authority has fined drugmaker GlaxoSmithKline $54.5 million for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith